These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4028597)

  • 1. Scintigraphic findings in primary amyloidosis of the heart and stomach.
    Shih WJ; DeLand FH; Domstad PA; Stahr BJ; Powell RD; Yoneda K
    Clin Nucl Med; 1985 Jul; 10(7):466-7. PubMed ID: 4028597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic considerations in cardiomyopathy: unique scintigraphic pattern of diffuse biventricular technetium-99m-pyrophosphate uptake in amyloid heart disease.
    Schiff S; Bateman T; Moffatt R; Davidson R; Berman D
    Am Heart J; 1982 Apr; 103(4 Pt 1):562-3. PubMed ID: 6278907
    [No Abstract]   [Full Text] [Related]  

  • 3. Scintigraphic characterization of amyloid cardiomyopathy.
    Li CK; Rabinovitch MA; Juni JE; Thrall JH; Pitt B; Das SK; Abrams GD; Helvie M
    Clin Nucl Med; 1985 Mar; 10(3):156-9. PubMed ID: 2985318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear imaging modalities for cardiac amyloidosis.
    Bokhari S; Shahzad R; Castaño A; Maurer MS
    J Nucl Cardiol; 2014 Feb; 21(1):175-84. PubMed ID: 24162886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Noninvasive diagnosis of cardiac involvement by technetium-99m-pyrophosphate (Tc-99m PYP) myocardial scintigraphy in 2 cases of familial amyloid polyneuropathy and 1 case of secondary amyloidosis].
    Takezaki M; Ishida Y; Morozumi T; Tani A; Sato H; Hori M; Kitabatake A; Kamada T; Kimura K; Kozuka T
    Kaku Igaku; 1989 Dec; 26(12):1537-43. PubMed ID: 2560088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aprotinin scintigraphy in amyloidosis].
    Haraldsen A; Eskild-Jensen A; Frøkiaer J
    Ugeskr Laeger; 2009 May; 171(22):1837-9. PubMed ID: 19486611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tc-99m(V) DMSA uptake in cardiac amyloidosis.
    Ohta H; Okada T; Furukawa Y; Yamamoto K; Miyaki Y; Shizuki K; Kotoura H; Endo K; Konishi J; Ohshima C
    Clin Nucl Med; 1991 Sep; 16(9):673-5. PubMed ID: 1657486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technetium-99m triethylene tetramine polystyrene resin gastric emptying studies in patients with various upper gastrointestinal diseases.
    Shih WJ; Domstad PA; DeLand FH
    Clin Nucl Med; 1985 Jul; 10(7):494-7. PubMed ID: 3928223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soft-tissue uptake of 99mTc-diphosphonate in systemic AL amyloidosis.
    Janssen S; van Rijswijk MH; Piers DA; de Jong GM
    Eur J Nucl Med; 1984; 9(12):538-41. PubMed ID: 6441712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis.
    Falk RH; Lee VW; Rubinow A; Hood WB; Cohen AS
    Am J Cardiol; 1983 Mar; 51(5):826-30. PubMed ID: 6299087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (99m)Tc-DPD scintigraphy as a novel imaging modality for identification of skeletal muscle amyloid deposition in light-chain amyloidosis.
    Hutt DF; Gilbertson J; Quigley AM; Wechalekar AD
    Amyloid; 2016 Jun; 23(2):134-5. PubMed ID: 26981883
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary amyloid polyneuropathy with myocardial uptake of technetium-99m-diphosphonate.
    Tamaoka A; Sonoh M; Sakuta M
    Ann Neurol; 1987 Jan; 21(1):110-1. PubMed ID: 3030187
    [No Abstract]   [Full Text] [Related]  

  • 13. Technetium 99m-pyrophosphate scintigraphy in amyloid cardiomyopathy.
    Ptacin MJ; Bamrah V; Duthie E
    Wis Med J; 1985 Mar; 84(3):25-7. PubMed ID: 2986368
    [No Abstract]   [Full Text] [Related]  

  • 14. Radionuclide imaging in primary amyloidosis with liver involvement.
    Chen SD; Kao CH; Poon SK
    Clin Nucl Med; 1998 Jun; 23(6):374-6. PubMed ID: 9619324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro affinity of 99Tcm-labelled N2S2 conjugates of chrysamine G for amyloid deposits of systemic amyloidosis.
    Dezutter NA; Sciot RM; de Groot TJ; Bormans GM; Verbruggen AM
    Nucl Med Commun; 2001 May; 22(5):553-8. PubMed ID: 11388578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myocardial scintigraphic studies with 123I-MIBG, 201Tl and 99mTc-PYP in patients with cardiac amyloidosis].
    Fujii T; Tanaka M; Yazaki Y; Kitabayashi H; Koizumi T; Hongo M; Sekiguchi M; Itoh A; Gomi T; Yano K
    Kaku Igaku; 1997 Nov; 34(11):1033-9. PubMed ID: 9455044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myocardial pyrophosphate uptake in cardiac amyloidosis: report of case].
    Redondo F; González P; Ramírez A
    Rev Med Chil; 2002 Mar; 130(3):315-8. PubMed ID: 12043375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Negativity of myocardial scintigraphy with technetium-pyrophosphate in a case of primary cardiac amyloidosis].
    Volpi A; Cavalli A; Maggioni AP; Inglese E; Rovelli GE; Neri R; Salvi A
    G Ital Cardiol; 1985 Sep; 15(9):925-9. PubMed ID: 3002892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technetium-99m(V)dimercaptosuccinic acid uptake in intra-abdominal massive deposit of amyloid protein.
    Kobayashi H; Sakahara H; Itoh T; Kudoh T; Takagi T; Shibuya K; Nomura S; Hosono M; Endo K; Konishi J
    J Nucl Med; 1993 May; 34(5):815-7. PubMed ID: 8386760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal scintigraphic evolution in AA hepatic amyloidosis.
    Lomeña F; Roselló R; Pons F; Grau M; García A; Catafau A; Setoain J
    Clin Nucl Med; 1988 Mar; 13(3):194-6. PubMed ID: 2838214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.